Surgery, hyperfractionated craniospinal irradiation, and adjuvant chemotherapy in the management of supratentorial embryonal neuroepithelial neoplasms in children

Edward C. Halperin, Henry S. Friedman, S. Clifford Schold, Herbert E. Fuchs, W. Jerry Oakes, Beverly Hockenberger, Peter C. Burger

Research output: Contribution to journalArticle

Abstract

Supratentorial embryonal neuroepithelial tumors are undifferentiated neoplasms. We have used this term in preference to the controversial classification primitive neuroectodermal tumors (PNET). These lesions in children are malignant neoplasms which are usually fatal within 2 years of diagnosis in spite of therapy with surgery, radiotherapy, and chemotherapy. We have adopted an aggressive approach to the treatment of these tumors with surgical resection, hyperfractionated craniospinal irradiation of 30.6-43.9 Gy followed by a tumor boost to a total dose of 50-63.7 Gy, and adjuvant chemotherapy with cyclophosphamide, vincristine, and cis-platinum. We have treated five children, aged 4-18 years, with this approach. In contrast to the results reported in the literature, four children are alive without evidence of tumor from 4.3 to 8.0 years following diagnosis. One has suffered a tumor relapse at 2.3 years following diagnosis but remains alive. The basis of our therapeutic strategy for childhood supratentorial embryonal neuroepithelial tumors and the implications of our clinical results are discussed.

Original languageEnglish (US)
Pages (from-to)278-283
Number of pages6
JournalSurgical Neurology
Volume40
Issue number4
DOIs
StatePublished - 1993
Externally publishedYes

Fingerprint

Craniospinal Irradiation
Supratentorial Neoplasms
Neuroepithelial Neoplasms
Germ Cell and Embryonal Neoplasms
Adjuvant Chemotherapy
Neoplasms
Primitive Neuroectodermal Tumors
Vincristine
Cyclophosphamide
Cisplatin
Radiotherapy
Therapeutics
Recurrence
Drug Therapy

Keywords

  • Brain neoplasms
  • Primitive neuroectodermal tumors
  • Radiotherapy

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Surgery, hyperfractionated craniospinal irradiation, and adjuvant chemotherapy in the management of supratentorial embryonal neuroepithelial neoplasms in children. / Halperin, Edward C.; Friedman, Henry S.; Clifford Schold, S.; Fuchs, Herbert E.; Jerry Oakes, W.; Hockenberger, Beverly; Burger, Peter C.

In: Surgical Neurology, Vol. 40, No. 4, 1993, p. 278-283.

Research output: Contribution to journalArticle

Halperin, Edward C. ; Friedman, Henry S. ; Clifford Schold, S. ; Fuchs, Herbert E. ; Jerry Oakes, W. ; Hockenberger, Beverly ; Burger, Peter C. / Surgery, hyperfractionated craniospinal irradiation, and adjuvant chemotherapy in the management of supratentorial embryonal neuroepithelial neoplasms in children. In: Surgical Neurology. 1993 ; Vol. 40, No. 4. pp. 278-283.
@article{3f0fa114977a49b4a0e67233aa0d7995,
title = "Surgery, hyperfractionated craniospinal irradiation, and adjuvant chemotherapy in the management of supratentorial embryonal neuroepithelial neoplasms in children",
abstract = "Supratentorial embryonal neuroepithelial tumors are undifferentiated neoplasms. We have used this term in preference to the controversial classification primitive neuroectodermal tumors (PNET). These lesions in children are malignant neoplasms which are usually fatal within 2 years of diagnosis in spite of therapy with surgery, radiotherapy, and chemotherapy. We have adopted an aggressive approach to the treatment of these tumors with surgical resection, hyperfractionated craniospinal irradiation of 30.6-43.9 Gy followed by a tumor boost to a total dose of 50-63.7 Gy, and adjuvant chemotherapy with cyclophosphamide, vincristine, and cis-platinum. We have treated five children, aged 4-18 years, with this approach. In contrast to the results reported in the literature, four children are alive without evidence of tumor from 4.3 to 8.0 years following diagnosis. One has suffered a tumor relapse at 2.3 years following diagnosis but remains alive. The basis of our therapeutic strategy for childhood supratentorial embryonal neuroepithelial tumors and the implications of our clinical results are discussed.",
keywords = "Brain neoplasms, Primitive neuroectodermal tumors, Radiotherapy",
author = "Halperin, {Edward C.} and Friedman, {Henry S.} and {Clifford Schold}, S. and Fuchs, {Herbert E.} and {Jerry Oakes}, W. and Beverly Hockenberger and Burger, {Peter C.}",
year = "1993",
doi = "10.1016/0090-3019(93)90138-Q",
language = "English (US)",
volume = "40",
pages = "278--283",
journal = "World Neurosurgery",
issn = "1878-8750",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Surgery, hyperfractionated craniospinal irradiation, and adjuvant chemotherapy in the management of supratentorial embryonal neuroepithelial neoplasms in children

AU - Halperin, Edward C.

AU - Friedman, Henry S.

AU - Clifford Schold, S.

AU - Fuchs, Herbert E.

AU - Jerry Oakes, W.

AU - Hockenberger, Beverly

AU - Burger, Peter C.

PY - 1993

Y1 - 1993

N2 - Supratentorial embryonal neuroepithelial tumors are undifferentiated neoplasms. We have used this term in preference to the controversial classification primitive neuroectodermal tumors (PNET). These lesions in children are malignant neoplasms which are usually fatal within 2 years of diagnosis in spite of therapy with surgery, radiotherapy, and chemotherapy. We have adopted an aggressive approach to the treatment of these tumors with surgical resection, hyperfractionated craniospinal irradiation of 30.6-43.9 Gy followed by a tumor boost to a total dose of 50-63.7 Gy, and adjuvant chemotherapy with cyclophosphamide, vincristine, and cis-platinum. We have treated five children, aged 4-18 years, with this approach. In contrast to the results reported in the literature, four children are alive without evidence of tumor from 4.3 to 8.0 years following diagnosis. One has suffered a tumor relapse at 2.3 years following diagnosis but remains alive. The basis of our therapeutic strategy for childhood supratentorial embryonal neuroepithelial tumors and the implications of our clinical results are discussed.

AB - Supratentorial embryonal neuroepithelial tumors are undifferentiated neoplasms. We have used this term in preference to the controversial classification primitive neuroectodermal tumors (PNET). These lesions in children are malignant neoplasms which are usually fatal within 2 years of diagnosis in spite of therapy with surgery, radiotherapy, and chemotherapy. We have adopted an aggressive approach to the treatment of these tumors with surgical resection, hyperfractionated craniospinal irradiation of 30.6-43.9 Gy followed by a tumor boost to a total dose of 50-63.7 Gy, and adjuvant chemotherapy with cyclophosphamide, vincristine, and cis-platinum. We have treated five children, aged 4-18 years, with this approach. In contrast to the results reported in the literature, four children are alive without evidence of tumor from 4.3 to 8.0 years following diagnosis. One has suffered a tumor relapse at 2.3 years following diagnosis but remains alive. The basis of our therapeutic strategy for childhood supratentorial embryonal neuroepithelial tumors and the implications of our clinical results are discussed.

KW - Brain neoplasms

KW - Primitive neuroectodermal tumors

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=0027373607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027373607&partnerID=8YFLogxK

U2 - 10.1016/0090-3019(93)90138-Q

DO - 10.1016/0090-3019(93)90138-Q

M3 - Article

VL - 40

SP - 278

EP - 283

JO - World Neurosurgery

JF - World Neurosurgery

SN - 1878-8750

IS - 4

ER -